James Signorovitch

14PUBLICATIONS

63CO-AUTHORS

Gene and molecular therapyNeurology and neuromuscular diseasesRespiratory diseasesMajor global burdens of diseaseMedical mycology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jun 04, 2026

Five-Year Outcomes With Delandistrogene Moxeparvovec in Patients With Duchenne Muscular Dystrophy: A Phase 1/2a Study.

|Mar 20, 2026

Motor Function and Growth Outcomes With Early Corticosteroid Initiation in Duchenne Muscular Dystrophy: An Adjusted Cross-Trial Comparison.

Emma Ciafaloni, Abigail Zion, Joanne Donovan

|Jul 18, 2025

Real-world phosphorodiamidate morpholino oligomer treatment patterns in Duchenne muscular dystrophy: a claims-based analysis.

Shannon Grabich, Brian Ung, Aalok Nadkar

|Jun 27, 2025

Predicting trajectories of the north star ambulatory assessment total score in Duchenne muscular dystrophy.

Francesco Muntoni, James Signorovitch, Nathalie Goemans

|Mar 12, 2025

Treatment patterns and healthcare resource utilization in ruxolitinib-treated patients with myelofibrosis with and without anemia: a real-world analysis.

Tom Liu, Mirko Fillbrunn, Shiyuan Zhang

|Nov 11, 2024

Assessment of Phosphorodiamidate Morpholino Oligomer Treatment Patterns for Patients with Duchenne Muscular Dystrophy: A MarketScan Claims Analysis.

Alexa C Klimchak, James Signorovitch, Bryan Innis

Pageof 3

Frequent Collaborators

Craig McDonald

Susan J Ward

Erik H Niks

Nicolae Done

Isabelle Lousada

Robert C Griggs

Zarife Sahenk

Linda P Lowes

Megan A Iammarino

Lindsay N Alfano

Frequent Collaborators

Craig McDonald

Susan J Ward

Erik H Niks

Nicolae Done